Medtronic Total Assets 2006-2019 | MDT

Medtronic total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Medtronic total assets for the quarter ending January 31, 2019 were $88.730B, a 7.38% decline year-over-year.
  • Medtronic total assets for 2018 were $91.393B, a 8.48% decline from 2017.
  • Medtronic total assets for 2017 were $99.857B, a 0.21% increase from 2016.
  • Medtronic total assets for 2016 were $99.644B, a 6.6% decline from 2015.
Medtronic Annual Total Assets
(Millions of US $)
2018 $91,393
2017 $99,857
2016 $99,644
2015 $106,685
2014 $37,943
2013 $34,900
2012 $32,818
2011 $30,675
2010 $28,090
2009 $23,588
2008 $22,198
2007 $19,512
2006 $19,665
2005 $16,617
Medtronic Quarterly Total Assets
(Millions of US $)
Q3 2019 $88,730
Q2 2018 $88,150
Q1 2018 $89,721
Q4 2018 $91,393
Q3 2018 $95,800
Q2 2017 $94,458
Q1 2017 $100,250
Q4 2017 $99,857
Q3 2017 $97,578
Q2 2016 $98,406
Q1 2016 $98,601
Q4 2016 $99,644
Q3 2016 $102,706
Q2 2015 $104,945
Q1 2015 $104,626
Q4 2015 $106,685
Q3 2015 $55,233
Q2 2014 $38,780
Q1 2014 $37,554
Q4 2014 $37,943
Q3 2014 $37,231
Q2 2013 $36,468
Q1 2013 $34,972
Q4 2013 $34,900
Q3 2013 $34,949
Q2 2012 $33,960
Q1 2012 $33,252
Q4 2012 $32,818
Q3 2012 $31,911
Q2 2011 $31,753
Q1 2011 $31,091
Q4 2011 $30,675
Q3 2011 $30,597
Q2 2010 $29,311
Q1 2010 $28,660
Q4 2010 $28,090
Q3 2010 $25,168
Q2 2009 $24,284
Q1 2009 $23,574
Q4 2009 $23,588
Q3 2009 $22,764
Q2 2008 $22,033
Q1 2008 $22,733
Q4 2008 $22,198
Q3 2008 $21,412
Q2 2007 $20,586
Q1 2007 $19,660
Q4 2007 $19,512
Q3 2007 $19,572
Q2 2006 $18,896
Q1 2006 $20,181
Q4 2006 $19,665
Q3 2006 $18,339
Q2 2005 $17,768
Q1 2005 $16,917
Q4 2005 $16,617
Q3 2005 $15,695
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $114.856B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.809B 26.28
Stryker (SYK) United States $69.039B 24.64
Boston Scientific (BSX) United States $49.279B 23.63
Baxter (BAX) United States $38.988B 25.01
Zimmer Biomet Holdings (ZBH) United States $25.460B 16.29
Smith & Nephew SNATS (SNN) United Kingdom $16.746B 0.00
Canopy Growth (CGC) Canada $16.646B 0.00
ResMed (RMD) United States $14.578B 27.64
Aurora Cannabis (ACB) Canada $9.230B 65.07
Bio-Rad Laboratories (BIO) United States $8.754B 50.22
Perrigo (PRGO) Ireland $6.685B 10.84
Hill-Rom Holdings (HRC) United States $6.417B 19.85
Insulet (PODD) United States $4.971B 1666.40
GW Pharmaceuticals (GWPH) United Kingdom $4.857B 0.00
ICU Medical (ICUI) United States $4.694B 29.07
Haemonetics (HAE) United States $4.319B 38.31
Hutchison China MediTech (HCM) China $3.951B 0.00
Agios Pharmaceuticals (AGIO) United States $3.335B 0.00
NuVasive (NUVA) United States $3.048B 26.48
Neogen (NEOG) United States $3.014B 49.01
Quidel (QDEL) United States $2.477B 22.16
National Vision Holdings (EYE) United States $2.284B 44.94
Aphria (APHA) $1.955B 0.00
HEXO (HEXO) $1.502B 0.00
Phibro Animal Health (PAHC) United States $1.342B 19.28
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.222B 877.50
AtriCure (ATRC) United States $1.081B 0.00
Lantheus Holdings (LNTH) United States $0.962B 26.00
Omeros (OMER) United States $0.930B 0.00
PetIQ (PETQ) United States $0.874B 25.02
Cerus (CERS) United States $0.826B 0.00
MacroGenics (MGNX) United States $0.805B 0.00
NanoString Technologies (NSTG) United States $0.759B 0.00
Evolus (EOLS) United States $0.721B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.720B 24.51
TG Therapeutics (TGTX) United States $0.706B 0.00
OraSure Technologies (OSUR) United States $0.596B 25.95
Surmodics (SRDX) United States $0.585B 85.02
LeMaitre Vascular (LMAT) United States $0.554B 26.32
Meridian Bioscience (VIVO) United States $0.551B 16.42
Quanterix (QTRX) United States $0.500B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.344B 0.00
Insys Therapeutics (INSY) United States $0.321B 0.00
Utah Medical Products (UTMD) United States $0.319B 20.75
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.283B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.223B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.175B 18.69
Bovie Medical (APYX) United States $0.149B 0.00
Chimerix (CMRX) United States $0.129B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.088B 20.27
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 12.64